Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Many studies have shown that short telomere length (TL) is associated with high oxidative stress and various age-related diseases. Parkinson's disease (PD) is an age-related disease, and although its pathogenic mechanism is uncertain, oxidative stress is believed to be implicated in this pathology. The aim of this case-control study was to assess both TL and the different markers of oxidative stress in elderly patients with PD compared to age control subjects. METHODS: 20 PD patients and 15 age-matched controls, >65 years were studied. TL was measured by Southern blotting from DNA samples extracted from white blood cells. Superoxide dismutase (SOD) activity and plasma levels of total glutathione and protein carbonyls were determined. RESULTS: There was a trend for lower TL in PD patients: 6.06 ± 0.81 kb in PD versus 6.45 ± 0.73 kb in controls (p = 0.08). No significant difference was found between the two groups in terms of oxidative stress markers. In controls, age was the main determinant of telomere shortening (r = -0.547; p = 0.03) whereas, in PD patients, telomere shortening was mainly dependent on plasmatic concentrations of carbonyl proteins (r= -0.544; p=0.044). In PD patients, a negative association was observed between plasma carbonyl protein levels and SOD activity (r= -0.622, p=0.004). CONCLUSIONS: In PD, TL is shorter in presence of high oxidative stress as measured by carbonyl protein levels. The absence of telomere attrition with age among patients with PD could reflect a telomere regulation by mechanisms other than age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 1×
“Despite the fact that oxidative stress has been proposed to play an important role in the pathogenesis of PD (12, 13, 23), no significant differences in markers of oxidative stress, namely plasma total GSH, protein carbonyls and SOD activity, were observed in the present study between PD patients…”
Oxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524 · cited 1×
“Experimental evidence, obtained from various cell types (3-5), indicate that oxidative stress accelerates the attrition of telomeres.”
Telomere loss: mitotic clock or genetic time bomb?
Harley, C. B. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90018-7 · Cited by 1,139
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
Matthews, C., Gorenne, I., Scott, S., Figg, N., Kirkpatrick, P., Ritchie, A., Goddard, M., & Bennett, M. (2006) · Circulation Research · doi:10.1161/01.res.0000233315.38086.bc · Cited by 615 · cited 1×
“Matthews and colleagues suggested that human atherosclerosis is characterized by senescence of vascular smooth muscle cells, accelerated by oxidative stress-induced DNA damage, inhibition of telomerase and marked telomere shortening (4).”
Telomere shortening in atherosclerosis
Samani, N. J., Boultby, R., Butler, R., Thompson, J. R., & Goodall, A. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05633-1 · Cited by 609
Kurz, D. J., Decary, S., Hong, Y., Trivier, E., Akhmedov, A., & Erusalimsky, J. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01097 · Cited by 499
Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive Subjects
Benetos, A., Gardner, J. P., Zureik, M., Labat, C., Xiaobin, L., Adamopoulos, C., Temmar, M., Bean, K. E., Thomas, F., & Aviv, A. (2004) · Hypertension · doi:10.1161/01.hyp.0000113081.42868.f4 · Cited by 313 · cited 3×
“The difference in telomere length of 0.4 kb observed between the two groups is comparable to differences reported in previous studies between controls and patients with different age-related alterations and diseases such as aortic stiffness (8, 9) carotid atherosclerosis (7) and dementia (10, 20).”
InfluentialTelomeres and human aging: facts and fibs
Aviv, A. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.51.pe43 · Cited by 198
Research works printed but not linked: 27
- Cattan, 2008, Chronic oxidative stress induces a tissuespecific reduction in telomere length in CAST/Ei mice, Free Radic Biol Med, 44, 1592, 10.1016/j.freeradbiomed.2008.01.007 · DOI
- Chang, 1995, Telomere length and replicative aging in human vascular tissues, Proc Natl Acad Sci U S A, 92, 11190, 10.1073/pnas.92.24.11190 · DOI · Paper page
- Benetos, 2001, Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity, Hypertension, 37, 381, 10.1161/01.HYP.37.2.381 · DOI · Paper page
- Jeanclos, 2000, Telomere length inversely correlates with pulse pressure and is highly familial, Hypertension, 36, 195, 10.1161/01.HYP.36.2.195 · DOI · Paper page
- Panossian, 2003, Telomere shortening in T cells correlates with Alzheimer's disease status, Neurobiol Aging, 24, 77, 10.1016/S0197-4580(02)00043-X · DOI · Paper page
- Dexter, 1994, Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study, Mov Disord, 9, 92, 10.1002/mds.870090115 · DOI · Paper page
- Wang, 2008, Telomere length and risk of Parkinson's disease, Mov Disord, 23, 302, 10.1002/mds.21867 · DOI · Paper page
- Guan, 2008, A percentage analysis of the telomere length in Parkinson's disease patients, J Gerontol A Biol Sci Med Sci, 63, 467, 10.1093/gerona/63.5.467 · DOI · Paper page
- Dragonas, 2009, Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease, Clin Chem Lab Med, 47, 894, 10.1515/CCLM.2009.205 · DOI · Paper page
- Ershler, 2001, The value of the SENIEUR protocol: distinction between “ideal aging” and clinical reality, Mech Ageing Dev, 122, 134, 10.1016/S0047-6374(00)00241-4 · DOI
- Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215 · DOI · Paper page
- Tentolouris, 2007, White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria, Diabetes Care, 30, 2909, 10.2337/dc07-0633 · DOI
- Martin-Ruiz, 2006, Telomere length predicts poststroke mortality, dementia, and cognitive decline, Ann Neurol, 60, 174, 10.1002/ana.20869 · DOI · Paper page
- Lev, 2003, Apoptosis and Parkinson's disease, Prog Neuropsychopharmacol Biol Psychiatry, 27, 245, 10.1016/S0278-5846(03)00019-8 · DOI · Paper page
- Nawrot, 2004, Telomere length and possible link to X chromosome, Lancet, 363, 507, 10.1016/S0140-6736(04)15535-9 · DOI · Paper page
- Prigione, 2006, Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage, Neurobiol Dis, 23, 36, 10.1016/j.nbd.2006.01.013 · DOI
- Prigione, 2009, Increased oxidative stress in lymphocytes from untreated Parkinson's disease patients, Parkinsonism Relat Disord, 15, 327, 10.1016/j.parkreldis.2008.05.013 · DOI
- Serra, 2001, Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients, J Neural Transm, 108, 1135, 10.1007/s007020170003 · DOI
- Younes-Mhenni, 2007, Peripheral blood markers of oxidative stress in Parkinson's disease, Eur Neurol, 58, 78, 10.1159/000103641 · DOI
- Martin, 2009, Glutathione—a review on its role and significance in Parkinson's disease, FASEB J, 23, 3263, 10.1096/fj.08-125443 · DOI · Paper page
- Alam, 1997, A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease, J Neurochem, 69, 1326, 10.1046/j.1471-4159.1997.69031326.x · DOI · Paper page
- Sudha, 2003, Free radical toxicity and antioxidants in Parkinson's disease, Neurol India, 51, 60
- Kocaturk, 2000, Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease, Pathophysiology, 7, 63, 10.1016/S0928-4680(00)00030-4 · DOI
- Abraham, 2005, Erythrocyte antioxidant enzymes in Parkinson's disease, Indian J Med Res, 121, 111
- Bostantjopoulou, 1997, Superoxide dismutase activity in early and advanced Parkinson's disease, Funct Neurol, 12, 63
- Ihara, 1999, Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data, J Neurol Sci, 170, 90, 10.1016/S0022-510X(99)00192-6 · DOI
- De Meyer, 2008, Studying telomeres in a longitudinal population based study, Front Biosci, 13, 2960, 10.2741/2901 · DOI · Paper page
Cited by
A systematic review of leukocyte telomere length and age in adults
Müezzinler, A., Zaineddin, A. K., & Brenner, H. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.01.003 · Cited by 474
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients
Horvath, S., & Ritz, B. R. (2015) · Aging · doi:10.18632/aging.100859 · Cited by 436
Telomere Biology and Human Phenotype
Turner, K., Vasu, V., & Griffin, D. (2019) · Cells · doi:10.3390/cells8010073 · Cited by 385
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Sanders, L. H., & Timothy Greenamyre, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.003 · Cited by 345
Metadata
- Authors
- Watfa, G., Dragonas, C., Brosche, T., Dittrich, R., Sieber, C. C., Alecu, C., Benetos, A., & Nzietchueng, R.
- Venue
- The Journal of nutrition, health and aging
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 15
- Issue
- 4
- Pages
- 277-281
- ISSN
- 1279-7707 (ISSN-L)
- OpenAlex
- W2021667351
- Cited by
- 70
- References
- 9
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4648 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease. https://app.cochat.ai/papers/10.1007/s12603-010-0275-7
- The paper
- Watfa, G., Dragonas, C., Brosche, T., Dittrich, R., Sieber, C. C., Alecu, C., Benetos, A., & Nzietchueng, R. (2011). Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease. The Journal of nutrition, health and aging. https://doi.org/10.1007/s12603-010-0275-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.